| |
|
|
|
Registro Completo |
|
Biblioteca(s): |
Embrapa Agroindústria Tropical. |
|
Data corrente: |
16/02/2011 |
|
Data da última atualização: |
25/05/2017 |
|
Tipo da produção científica: |
Resumo em Anais de Congresso |
|
Autoria: |
GALAS, K. S.; BRUNO, L. M.; SANTOS, J. G. dos; MIRANDA, K. W. E.; AZEREDO, H. M. C. de. |
|
Afiliação: |
Kandarpa Silva Galas, UECE; LAURA MARIA BRUNO, CNPAT; Jessika Gonçalves dos Santos, UECE; Kelvi Wilson Evaristo Miranda, UECE; HENRIETTE MONTEIRO C DE AZEREDO, CNPAT. |
|
Título: |
Avaliação microbiológica de filmes comestíveis à base de polpa de acerola adicionado de ácido sórbico. |
|
Ano de publicação: |
2010 |
|
Fonte/Imprenta: |
In: CONGRESSO BRASILEIRO DE CIÊNCIA E TECNOLOGIA DE ALIMENTOS, 22., 2010, Salvador. Resumos... Salvador: Sociedade Brasileira de Ciência e Tecnologia de Alimentos, 2010. |
|
Páginas: |
1 CD-ROM. |
|
Idioma: |
Português |
|
Palavras-Chave: |
Agente antimicrobiano; Conservante; Levedura. |
|
Thesagro: |
Escherichia Coli; Staphylococcus Aureus. |
|
Categoria do assunto: |
-- |
|
URL: |
https://ainfo.cnptia.embrapa.br/digital/bitstream/item/34335/1/RE10049.pdf
|
|
Marc: |
LEADER 00786nam a2200217 a 4500
001 1877455
005 2017-05-25
008 2010 bl uuuu u00u1 u #d
100 1 $aGALAS, K. S.
245 $aAvaliação microbiológica de filmes comestíveis à base de polpa de acerola adicionado de ácido sórbico.
260 $aIn: CONGRESSO BRASILEIRO DE CIÊNCIA E TECNOLOGIA DE ALIMENTOS, 22., 2010, Salvador. Resumos... Salvador: Sociedade Brasileira de Ciência e Tecnologia de Alimentos$c2010
300 $a1 CD-ROM.
650 $aEscherichia Coli
650 $aStaphylococcus Aureus
653 $aAgente antimicrobiano
653 $aConservante
653 $aLevedura
700 1 $aBRUNO, L. M.
700 1 $aSANTOS, J. G. dos
700 1 $aMIRANDA, K. W. E.
700 1 $aAZEREDO, H. M. C. de
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Agroindústria Tropical (CNPAT) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
URL |
Voltar
|
|
|
 | Acesso ao texto completo restrito à biblioteca da Embrapa Gado de Leite. Para informações adicionais entre em contato com cnpgl.biblioteca@embrapa.br. |
Registro Completo
|
Biblioteca(s): |
Embrapa Gado de Leite. |
|
Data corrente: |
11/08/2021 |
|
Data da última atualização: |
11/08/2021 |
|
Tipo da produção científica: |
Nota Técnica/Nota Científica |
|
Autoria: |
FONSECA, M. D. M.; MAIA, J. M. S.; VARAGO, F. C.; GERN, J. C.; CARVALHO, W. A.; SILVA, S. R.; MOSQUEIRA, V. C. F.; BRANDAO, H. de M.; GUIMARÃES, A. S. |
|
Afiliação: |
Universidade Federal de Lavras; Universidade Federal de Lavras; JULIANA CARINE GERN, CNPGL; WANESSA ARAUJO CARVALHO, CNPGL; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; HUMBERTO DE MELLO BRANDAO, CNPGL; ALESSANDRO DE SA GUIMARAES, CNPGL. |
|
Título: |
Cloxacillin nanostructured formulation for the treatment of bovine keratoconjunctivitis. |
|
Ano de publicação: |
2020 |
|
Fonte/Imprenta: |
Veterinary and Animal Science, v. 9, 100089, 2020. |
|
DOI: |
https://doi.org/10.1016/j.vas.2020.100089 |
|
Idioma: |
Inglês |
|
Notas: |
Short communication. |
|
Conteúdo: |
Infectious bovine keratoconjunctivitis (IBK) is a widespread, contagious ocular disease that affects cattle, especially dairy breeds. The disease is caused by Gram-negative bacteria mainly Moraxella bovis, and its treatment consists of parenteral or topic antibiotic therapy. The topic treatment approach is used more commonly in lactating cows, to avoid milk disposal. However, treatment failures are common, because the antibiotic is removed during lacrimation. This study aimed to evaluate the susceptibility of commercial cloxacillin and evaluate the efficacy of nanostructured cloxacillin in clinical cases of IBK by Moraxella. The minimum inhibitory concentration (MIC) of nanoparticle cloxacillin nanocoated, the nanoparticle without the antibiotic and the commercial cloxacillin were determined in vitro with field samples of Moraxella ovis (5) and Moraxella bovis (5). The efficiency of nanoparticles was tested in three cows naturally infected that were treated with 1.0 mL (with 0.32 mg of nanostructured cloxacillin) for the ocular route. Moraxella bovis was isolated and identified by biochemical and molecular methods before the treatment. The animals were treated every 12 h for six days. The cure was considered by the absence of clinical symptoms and bacteria after treatment. The mucoadhesive nanoparticlebased formulation promoted clinical cure with a low number of doses of antibiotics, probably due to the maintenance of the MIC in the ocular mucosa for longer due to the mucoadhesive characteristics of the nanoparticle. The results indicate that the use of nanocoated cloxacillin is possible to control infectious bovine keratoconjunctivitis. MenosInfectious bovine keratoconjunctivitis (IBK) is a widespread, contagious ocular disease that affects cattle, especially dairy breeds. The disease is caused by Gram-negative bacteria mainly Moraxella bovis, and its treatment consists of parenteral or topic antibiotic therapy. The topic treatment approach is used more commonly in lactating cows, to avoid milk disposal. However, treatment failures are common, because the antibiotic is removed during lacrimation. This study aimed to evaluate the susceptibility of commercial cloxacillin and evaluate the efficacy of nanostructured cloxacillin in clinical cases of IBK by Moraxella. The minimum inhibitory concentration (MIC) of nanoparticle cloxacillin nanocoated, the nanoparticle without the antibiotic and the commercial cloxacillin were determined in vitro with field samples of Moraxella ovis (5) and Moraxella bovis (5). The efficiency of nanoparticles was tested in three cows naturally infected that were treated with 1.0 mL (with 0.32 mg of nanostructured cloxacillin) for the ocular route. Moraxella bovis was isolated and identified by biochemical and molecular methods before the treatment. The animals were treated every 12 h for six days. The cure was considered by the absence of clinical symptoms and bacteria after treatment. The mucoadhesive nanoparticlebased formulation promoted clinical cure with a low number of doses of antibiotics, probably due to the maintenance of the MIC in the ocular mucosa for longer due to the mucoad... Mostrar Tudo |
|
Palavras-Chave: |
Ceratoconjuntivite; Cloxacilina; Nanoestrutura; Nanopartícula mucoadesiva. |
|
Thesagro: |
Bovino; Doença Animal; Moraxella Bovis. |
|
Categoria do assunto: |
L Ciência Animal e Produtos de Origem Animal |
|
Marc: |
LEADER 02630naa a2200325 a 4500
001 2133453
005 2021-08-11
008 2020 bl uuuu u00u1 u #d
024 7 $ahttps://doi.org/10.1016/j.vas.2020.100089$2DOI
100 1 $aFONSECA, M. D. M.
245 $aCloxacillin nanostructured formulation for the treatment of bovine keratoconjunctivitis.$h[electronic resource]
260 $c2020
500 $aShort communication.
520 $aInfectious bovine keratoconjunctivitis (IBK) is a widespread, contagious ocular disease that affects cattle, especially dairy breeds. The disease is caused by Gram-negative bacteria mainly Moraxella bovis, and its treatment consists of parenteral or topic antibiotic therapy. The topic treatment approach is used more commonly in lactating cows, to avoid milk disposal. However, treatment failures are common, because the antibiotic is removed during lacrimation. This study aimed to evaluate the susceptibility of commercial cloxacillin and evaluate the efficacy of nanostructured cloxacillin in clinical cases of IBK by Moraxella. The minimum inhibitory concentration (MIC) of nanoparticle cloxacillin nanocoated, the nanoparticle without the antibiotic and the commercial cloxacillin were determined in vitro with field samples of Moraxella ovis (5) and Moraxella bovis (5). The efficiency of nanoparticles was tested in three cows naturally infected that were treated with 1.0 mL (with 0.32 mg of nanostructured cloxacillin) for the ocular route. Moraxella bovis was isolated and identified by biochemical and molecular methods before the treatment. The animals were treated every 12 h for six days. The cure was considered by the absence of clinical symptoms and bacteria after treatment. The mucoadhesive nanoparticlebased formulation promoted clinical cure with a low number of doses of antibiotics, probably due to the maintenance of the MIC in the ocular mucosa for longer due to the mucoadhesive characteristics of the nanoparticle. The results indicate that the use of nanocoated cloxacillin is possible to control infectious bovine keratoconjunctivitis.
650 $aBovino
650 $aDoença Animal
650 $aMoraxella Bovis
653 $aCeratoconjuntivite
653 $aCloxacilina
653 $aNanoestrutura
653 $aNanopartícula mucoadesiva
700 1 $aMAIA, J. M. S.
700 1 $aVARAGO, F. C.
700 1 $aGERN, J. C.
700 1 $aCARVALHO, W. A.
700 1 $aSILVA, S. R.
700 1 $aMOSQUEIRA, V. C. F.
700 1 $aBRANDAO, H. de M.
700 1 $aGUIMARÃES, A. S.
773 $tVeterinary and Animal Science$gv. 9, 100089, 2020.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Gado de Leite (CNPGL) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
Fechar
|
| Nenhum registro encontrado para a expressão de busca informada. |
|
|
